[go: up one dir, main page]

CN116514864A - Preparation method of (2S, 4R) -1- (tert-butyloxycarbonyl) -4- (tert-butyldimethylsilyloxy) -2-methylpyrrolidine-2-carboxylic acid - Google Patents

Preparation method of (2S, 4R) -1- (tert-butyloxycarbonyl) -4- (tert-butyldimethylsilyloxy) -2-methylpyrrolidine-2-carboxylic acid Download PDF

Info

Publication number
CN116514864A
CN116514864A CN202310473843.2A CN202310473843A CN116514864A CN 116514864 A CN116514864 A CN 116514864A CN 202310473843 A CN202310473843 A CN 202310473843A CN 116514864 A CN116514864 A CN 116514864A
Authority
CN
China
Prior art keywords
reaction
butyldimethylsilyloxy
methylpyrrolidine
carboxylic acid
tert
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN202310473843.2A
Other languages
Chinese (zh)
Inventor
陈建芳
刘宁宁
池艳妮
张卫
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nanjing Youfu Pharmaceutical Technology Co ltd
Original Assignee
Nanjing Youfu Pharmaceutical Technology Co ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nanjing Youfu Pharmaceutical Technology Co ltd filed Critical Nanjing Youfu Pharmaceutical Technology Co ltd
Priority to CN202310473843.2A priority Critical patent/CN116514864A/en
Publication of CN116514864A publication Critical patent/CN116514864A/en
Pending legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02Silicon compounds
    • C07F7/08Compounds having one or more C—Si linkages
    • C07F7/18Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages
    • C07F7/1804Compounds having Si-O-C linkages
    • C07F7/1872Preparation; Treatments not provided for in C07F7/20
    • C07F7/188Preparation; Treatments not provided for in C07F7/20 by reactions involving the formation of Si-O linkages
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02Silicon compounds
    • C07F7/08Compounds having one or more C—Si linkages
    • C07F7/18Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages
    • C07F7/1804Compounds having Si-O-C linkages
    • C07F7/1872Preparation; Treatments not provided for in C07F7/20
    • C07F7/1892Preparation; Treatments not provided for in C07F7/20 by reactions not provided for in C07F7/1876 - C07F7/1888
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)

Abstract

The invention belongs to the technical field of medical intermediates, and particularly relates to a preparation method of (2S, 4R) -1- (tert-butyloxycarbonyl) -4- (tert-butyldimethylsilyloxy) -2-methylpyrrolidine-2-carboxylic acid. The preparation method of the (2S, 4R) -1- (tert-butyloxycarbonyl) -4- (tert-butyldimethylsilyloxy) -2-methylpyrrolidine-2-carboxylic acid provided by the invention is a brand new preparation method and has the advantages of safety, environmental protection and easiness in large-scale production.

Description

Preparation method of (2S, 4R) -1- (tert-butyloxycarbonyl) -4- (tert-butyldimethylsilyloxy) -2-methylpyrrolidine-2-carboxylic acid
Technical Field
The invention belongs to the technical field of medical intermediates, and particularly relates to a preparation method of (2S, 4R) -1- (tert-butyloxycarbonyl) -4- (tert-butyldimethylsilyloxy) -2-methylpyrrolidine-2-carboxylic acid.
Background
(2S, 4R) -1- (tert-Butoxycarbonyl) -4- (tert-butyldimethylsilyloxy) -2-methylpyrrolidine-2-carboxylic acid is an important pharmaceutical intermediate with CAS number 1374161-77-9. The preparation principle of the existing method is as follows after searching:
the method adopts Boc-L-trans-hydroxyproline as a starting material, and obtains a target product through four steps of reactions. Step one, methyl esterification reaction is carried out by adopting thionyl chloride, more hydrogen chloride and sulfur dioxide irritant gas can be generated in reaction neutralization post-treatment, and the operation is more complicated; step two adopts methyl iodide with 3A type carcinogen and lower atmospheric boiling point as a methylating agent, has stronger toxicity and is not beneficial to mass preparation, and the yield of the intermediate obtained in step three is less ideal (77%).
Therefore, it is necessary to provide a novel, safe, environment-friendly process for preparing (2S, 4R) -1- (t-butyldimethylsilyloxy) -4- (t-butyldimethylsilyloxy) -2-methylpyrrolidine-2-carboxylic acid which is easy to mass-produce.
Disclosure of Invention
The present invention has been made to overcome the above-mentioned problems occurring in the prior art, and an object of the present invention is to provide a method for preparing (2 s,4 r) -1- (t-butyldimethylsilyloxy) -4- (t-butyldimethylsilyloxy) -2-methylpyrrolidine-2-carboxylic acid.
In order to achieve the technical purpose and the technical effect, the invention is realized by the following technical scheme:
a preparation method of (2S, 4R) -1- (tert-butyloxycarbonyl) -4- (tert-butyldimethylsilyloxy) -2-methylpyrrolidine-2-carboxylic acid comprises the steps of taking Boc-L-trans-hydroxyproline as a starting material, and performing four steps of methyl esterification, TBS protection, methylation and demethylation to obtain a finished product.
Further, the reaction in the first step is shown as a formula (I), and an intermediate A is obtained after the reaction:
further, the reaction in the first step comprises the following specific steps: sequentially adding methanol, p-toluenesulfonic acid and Boc-L-trans-hydroxyproline into a reaction kettle, stirring for dissolving, heating, stirring, and refluxing for reacting for a period of time; TLC monitoring the reaction completion of the raw materials, cooling to room temperature, transferring into a rotary evaporator, concentrating the reaction liquid, adding saturated sodium bicarbonate aqueous solution and ethyl acetate extraction liquid, extracting the aqueous phase with ethyl acetate, combining the organic phases, drying with anhydrous sodium sulfate, filtering to remove a drying agent, and concentrating the filtrate under reduced pressure to obtain an intermediate A.
Further, the reaction in the second step is shown in a formula (II), and an intermediate B is obtained after the reaction:
further, the reaction of the second step comprises the following specific steps: adding dichloromethane, imidazole and an intermediate A into a reaction kettle, stirring and cooling at 0 ℃, dissolving tert-butyl dimethyl chlorosilane with dichloromethane, then dropwise adding the mixture into a reaction system for reaction, and after the addition, keeping the temperature and stirring for reaction for a period of time; TLC monitors that the raw materials are completely reacted, saturated sodium bicarbonate aqueous solution is added for separating, an organic phase is washed by saturated sodium chloride aqueous solution, the organic phase is dried by anhydrous sodium sulfate, a drying agent is removed by filtration, the filtrate is concentrated under reduced pressure to remove the solvent to obtain a crude product, and the crude product is subjected to rapid silica gel column chromatography to obtain an intermediate B.
Further, the reaction in the third step is shown in a formula (III), and an intermediate C is obtained after the reaction:
further, the reaction in the third step comprises the following specific steps: adding dry tetrahydrofuran and an intermediate B into a reaction kettle, cooling and stirring at the temperature of minus 20 ℃ under the protection of nitrogen, taking tetrahydrofuran solution of lithium diisopropylamide, dripping the tetrahydrofuran solution into the reaction system by using a dry dripping funnel, carrying out heat preservation reaction for a period of time after the dripping is finished, taking methyl triflate, dripping the methyl triflate into the reaction system by using the dry dripping funnel, and carrying out heat preservation reaction for a period of time after the dripping is finished; HPLC monitors the reaction completion of the raw materials, drops saturated ammonium chloride aqueous solution to quench the reaction, adds ethyl acetate for extraction, extracts the aqueous phase with ethyl acetate, combines the organic phases and dries with anhydrous magnesium sulfate, filters to remove the desiccant, and evaporates to dryness to obtain intermediate C.
Further, the reaction in the fourth step is shown as a formula (IV), and a finished product is obtained after the reaction:
further, the reaction in the fourth step comprises the following specific steps: adding tetrahydrofuran, an intermediate C and water into a reaction kettle, stirring and dissolving at room temperature, adding lithium hydroxide into a reaction system, and carrying out heat preservation reaction for a period of time after adding; TLC monitors the completion of the reaction of the starting materials, drops saturated aqueous ammonium chloride solution to quench the reaction, extracts with ethyl acetate, extracts the aqueous phase with ethyl acetate, combines the organic phases and dries with anhydrous magnesium sulfate, filters off the drying agent, and evaporates to dryness to give the (2S, 4R) -1- (tert-butoxycarbonyl) -4- (tert-butyldimethylsilyloxy) -2-methylpyrrolidine-2-carboxylic acid product.
Further, the (2S, 4R) -1- (tert-butyloxycarbonyl) -4- (tert-butyldimethylsilyloxy) -2-methylpyrrolidine-2-carboxylic acid product is purified by the following steps: dispersing the crude product with n-hexane and methanol, heating to reflux and dissolve, stirring at a cooling rate of 10 ℃/h, cooling, crystallizing, maintaining at room temperature, stirring for a period of time, suction filtering, washing the filter cake with a solution prepared by n-hexane and methanol according to a volume ratio of 15:1, suction drying the filter cake, and vacuum drying at room temperature to obtain a refined finished product.
The beneficial effects of the invention are as follows:
the preparation of (2S, 4R) -1- (tert-butyloxycarbonyl) -4- (tert-butyldimethylsilyloxy) -2-methylpyrrolidine-2-carboxylic acid is carried out by taking Boc-L-trans-hydroxyproline as initial raw material, and carrying out four steps of reactions of methyl esterification, TBS protection reaction, methylation reaction and demethylation esterification reaction to obtain the finished product; the preparation method is a brand new preparation method and has the advantages of safety, environmental protection and easy scale-up production.
Of course, it is not necessary for any one product to practice the invention to achieve all of the advantages set forth above at the same time.
Drawings
In order to more clearly illustrate the technical solutions of the embodiments of the present invention, the drawings that are needed for the description of the embodiments will be briefly described below, and it is obvious that the drawings in the following description are only some embodiments of the present invention, and that other drawings may be obtained according to these drawings without inventive effort for a person skilled in the art.
FIG. 1 is a schematic diagram of LCMS detection results of the finished product of the present invention;
FIG. 2 is a schematic representation of HPLC detection results for the finished product of the present invention.
Detailed Description
The following description of the embodiments of the present invention will be made clearly and completely with reference to the accompanying drawings, in which it is apparent that the embodiments described are only some embodiments of the present invention, but not all embodiments. All other embodiments, which can be made by those skilled in the art based on the embodiments of the invention without making any inventive effort, are intended to be within the scope of the invention.
The concrete terms of the embodiment are as follows:
SM: boc-L-trans-hydroxyproline
Boc: boc-group
MeOH: methanol
PTS: para-toluene sulfonic acid
TBS: tertiary butyl dimethylsilyl group
DCM: dichloromethane (dichloromethane)
LDA: lithium diisopropylamide
THF: tetrahydrofuran (THF)
The specific embodiment of the invention is as follows:
example 1
A process for the preparation of (2 s,4 r) -1- (t-butoxycarbonyl) -4- (t-butyldimethylsilyloxy) -2-methylpyrrolidine-2-carboxylic acid, characterized in that: the preparation of the (2S, 4R) -1- (tert-butyloxycarbonyl) -4- (tert-butyldimethylsilyloxy) -2-methylpyrrolidine-2-carboxylic acid is to take Boc-L-trans-hydroxyproline as a starting raw material, and obtain a finished product through four steps of reactions including methyl esterification reaction, TBS protection reaction, methylation reaction and demethylation esterification reaction.
The reaction in the first step is shown in a formula (I), and an intermediate A is obtained after the reaction:
the reaction in the first step comprises the following specific steps: methanol (5.0L), PTS (59.6 g,0.2 eq) and SM (400 g,1.0 eq) were added into a reaction kettle in sequence, stirred and dissolved, heated and refluxed for 4h. TLC monitors that the raw materials are completely reacted, cooling to room temperature, transferring into a rotary evaporator, concentrating the reaction liquid to about 2L, adding saturated sodium bicarbonate aqueous solution (4L) and 5L ethyl acetate, extracting the aqueous phase twice with 2L ethyl acetate, combining the organic phase, drying with anhydrous sodium sulfate for 2h, filtering to remove a drying agent, concentrating the filtrate under reduced pressure to obtain 417.5g of crude oil of the intermediate A, and obtaining the yield of 98.4%.
Mass spectrometry: MS-ESI:246.1[ M+H ]] +
The reaction in the second step is shown in a formula (II), and an intermediate B is obtained after the reaction:
the second step of reaction comprises the following specific steps: dichloromethane (5L), imidazole (173.6, 1.5 eq) and intermediate a (417.5 g,1.0 eq) were added to the reaction vessel, stirred and cooled at 0 ℃, tert-butyldimethylchlorosilane (282.2 g,1.1 eq) was taken and dissolved in dichloromethane (1L), then the mixture was added dropwise to the reaction system, the mixture was reacted for 1 hour, and the reaction was carried out under heat preservation and stirring for 8 hours. TLC monitors that the raw materials are completely reacted, saturated sodium bicarbonate aqueous solution (4L) is added for separating, an organic phase is washed once by saturated sodium chloride aqueous solution (4L), the organic phase is dried by anhydrous sodium sulfate, the filtrate is filtered, the solvent is removed by decompression concentration, crude products are obtained, and the intermediate B pure product 545.8g is obtained by rapid silica gel column chromatography, and the yield is 89.2%.
Mass spectrometry: MS-ESI:360.4[ M+H ]] +
The reaction in the third step is shown in a formula (III), and an intermediate C is obtained after the reaction:
the reaction in the third step comprises the following specific steps: dried tetrahydrofuran (5L) and an intermediate B (545.8 g,1.0 eq.) are added into a reaction kettle, cooled and stirred at the temperature of minus 20 ℃ under the protection of nitrogen, 1mol/L of LDA tetrahydrofuran solution (1.67L, 1.1 eq.) is taken and added dropwise into the reaction system by using a dried dropping funnel, the reaction is carried out for 1.5 hours after the addition, the reaction is carried out for 0.5 hours after the addition, methyl triflate (266.4 g,1.05 eq.) is taken and added dropwise into the reaction system by using a dried dropping funnel, and the reaction is carried out for 6 hours after the addition. HPLC monitors the reaction completion of the raw materials, drops saturated ammonium chloride aqueous solution (4L) to quench the reaction, adds ethyl acetate (4L) to extract, extracts the aqueous phase twice with ethyl acetate (2L), combines the organic phases, dries with anhydrous magnesium sulfate, filters, evaporates to dryness to obtain intermediate C crude product 512.6g, yield: 90.4%.
Mass spectrometry: MS-ESI:374.5[ M+H ]] +
The fourth step of reaction is shown as a formula (IV), and a finished product is obtained after the reaction:
the reaction in the fourth step comprises the following specific steps: tetrahydrofuran (5L), intermediate C (512.6 g,1.0 eq.) and water (1L) were added to the reaction vessel, and the mixture was stirred and dissolved at room temperature, lithium hydroxide (65.9 g,2.0 eq.) was added to the reaction system, and the reaction was carried out at a constant temperature for 4 hours after the addition. TLC monitors the completion of the reaction of the raw materials, drops saturated ammonium chloride aqueous solution (4L) to quench the reaction, adds ethyl acetate (4L) to extract, extracts the aqueous phase twice with ethyl acetate (2L), combines the organic phases, dries with anhydrous magnesium sulfate, filters, and evaporates to obtain the crude product. Dispersing the crude product with n-hexane (8L) and methanol (1.5L), heating to reflux and dissolve, stirring at a cooling rate of 10 ℃/h, cooling and crystallizing, keeping the temperature and stirring for 2h at room temperature, filtering, and filtering a filter cake with n-hexane: the solution with methanol=15:1 is washed twice, the filter cake is pumped down, and the filter cake is dried for 12 hours at room temperature in vacuum, thus obtaining 411.9g of target pure product with yield: 83.5%.
Mass spectrometry: MS-ESI:360.6[ M+H ]] +
The results of the product related tests are shown in fig. 1-2.
The preferred embodiments of the invention disclosed above are intended only to assist in the explanation of the invention. The preferred embodiments are not exhaustive or to limit the invention to the precise form disclosed. Obviously, many modifications and variations are possible in light of the above teaching. The embodiments were chosen and described in order to best explain the principles of the invention and the practical application, to thereby enable others skilled in the art to best understand and utilize the invention. The invention is limited only by the claims and the full scope and equivalents thereof.

Claims (10)

1. A process for the preparation of (2 s,4 r) -1- (t-butoxycarbonyl) -4- (t-butyldimethylsilyloxy) -2-methylpyrrolidine-2-carboxylic acid, characterized in that: the preparation of the (2S, 4R) -1- (tert-butyloxycarbonyl) -4- (tert-butyldimethylsilyloxy) -2-methylpyrrolidine-2-carboxylic acid is to take Boc-L-trans-hydroxyproline as a starting raw material, and obtain a finished product through four steps of reactions including methyl esterification reaction, TBS protection reaction, methylation reaction and demethylation esterification reaction.
2. The process for preparing (2S, 4R) -1- (t-butoxycarbonyl) -4- (t-butyldimethylsilyloxy) -2-methylpyrrolidine-2-carboxylic acid according to claim 1, wherein the reaction in the first step is represented by the formula (I), wherein the intermediate A is obtained after the reaction:
3. the method for preparing (2 s,4 r) -1- (t-butoxycarbonyl) -4- (t-butyldimethylsilyloxy) -2-methylpyrrolidine-2-carboxylic acid according to claim 2, wherein the reaction of the first step comprises the following steps: sequentially adding methanol, p-toluenesulfonic acid and Boc-L-trans-hydroxyproline into a reaction kettle, stirring for dissolving, heating, stirring, and refluxing for reacting for a period of time; TLC monitoring the reaction completion of the raw materials, cooling to room temperature, transferring into a rotary evaporator, concentrating the reaction liquid, adding saturated sodium bicarbonate aqueous solution and ethyl acetate extraction liquid, extracting the aqueous phase with ethyl acetate, combining the organic phases, drying with anhydrous sodium sulfate, filtering to remove a drying agent, and concentrating the filtrate under reduced pressure to obtain an intermediate A.
4. The process for preparing (2S, 4R) -1- (t-butoxycarbonyl) -4- (t-butyldimethylsilyloxy) -2-methylpyrrolidine-2-carboxylic acid according to claim 3, wherein the reaction in the second step is represented by the following formula (II):
5. the method for preparing (2S, 4R) -1- (t-butoxycarbonyl) -4- (t-butyldimethylsilyloxy) -2-methylpyrrolidine-2-carboxylic acid according to claim 4, wherein the second step comprises the following steps: adding dichloromethane, imidazole and an intermediate A into a reaction kettle, stirring and cooling at 0 ℃, dissolving tert-butyl dimethyl chlorosilane with dichloromethane, then dropwise adding the mixture into a reaction system for reaction, and after the addition, keeping the temperature and stirring for reaction for a period of time; TLC monitors that the raw materials are completely reacted, saturated sodium bicarbonate aqueous solution is added for separating, an organic phase is washed by saturated sodium chloride aqueous solution, the organic phase is dried by anhydrous sodium sulfate, a drying agent is removed by filtration, the filtrate is concentrated under reduced pressure to remove the solvent to obtain a crude product, and the crude product is subjected to rapid silica gel column chromatography to obtain an intermediate B.
6. The process for preparing (2S, 4R) -1- (t-butoxycarbonyl) -4- (t-butyldimethylsilyloxy) -2-methylpyrrolidine-2-carboxylic acid according to claim 5, wherein the reaction in the third step is represented by the following formula (III):
7. the method for preparing (2 s,4 r) -1- (t-butoxycarbonyl) -4- (t-butyldimethylsilyloxy) -2-methylpyrrolidine-2-carboxylic acid according to claim 6, wherein the reaction in the third step comprises the following steps: adding dry tetrahydrofuran and an intermediate B into a reaction kettle, cooling and stirring at the temperature of minus 20 ℃ under the protection of nitrogen, taking tetrahydrofuran solution of lithium diisopropylamide, dripping the tetrahydrofuran solution into the reaction system by using a dry dripping funnel, carrying out heat preservation reaction for a period of time after the dripping is finished, taking methyl triflate, dripping the methyl triflate into the reaction system by using the dry dripping funnel, and carrying out heat preservation reaction for a period of time after the dripping is finished; HPLC monitors the reaction completion of the raw materials, drops saturated ammonium chloride aqueous solution to quench the reaction, adds ethyl acetate for extraction, extracts the aqueous phase with ethyl acetate, combines the organic phases and dries with anhydrous magnesium sulfate, filters to remove the desiccant, and evaporates to dryness to obtain intermediate C.
8. The process for preparing (2S, 4R) -1- (t-butoxycarbonyl) -4- (t-butyldimethylsilyloxy) -2-methylpyrrolidine-2-carboxylic acid according to claim 7, wherein the reaction in the fourth step is as shown in formula (IV), and the final product is obtained after the reaction:
9. the method for preparing (2 s,4 r) -1- (t-butoxycarbonyl) -4- (t-butyldimethylsilyloxy) -2-methylpyrrolidine-2-carboxylic acid according to claim 8, wherein the reaction in the fourth step is as follows: adding tetrahydrofuran, an intermediate C and water into a reaction kettle, stirring and dissolving at room temperature, adding lithium hydroxide into a reaction system, and carrying out heat preservation reaction for a period of time after adding; TLC monitors the completion of the reaction of the starting materials, drops saturated aqueous ammonium chloride solution to quench the reaction, extracts with ethyl acetate, extracts the aqueous phase with ethyl acetate, combines the organic phases and dries with anhydrous magnesium sulfate, filters off the drying agent, and evaporates to dryness to give the (2S, 4R) -1- (tert-butoxycarbonyl) -4- (tert-butyldimethylsilyloxy) -2-methylpyrrolidine-2-carboxylic acid product.
10. The process for preparing (2S, 4R) -1- (t-butyloxycarbonyl) -4- (t-butyldimethylsilyloxy) -2-methylpyrrolidine-2-carboxylic acid according to claim 9, wherein the refining of the (2S, 4R) -1- (t-butyloxycarbonyl) -4- (t-butyldimethylsilyloxy) -2-methylpyrrolidine-2-carboxylic acid product comprises the following steps: dispersing the crude product with n-hexane and methanol, heating to reflux and dissolve, stirring at a cooling rate of 10 ℃/h, cooling, crystallizing, maintaining at room temperature, stirring for a period of time, suction filtering, washing the filter cake with a solution prepared by n-hexane and methanol according to a volume ratio of 15:1, suction drying the filter cake, and vacuum drying at room temperature to obtain a refined finished product.
CN202310473843.2A 2023-04-28 2023-04-28 Preparation method of (2S, 4R) -1- (tert-butyloxycarbonyl) -4- (tert-butyldimethylsilyloxy) -2-methylpyrrolidine-2-carboxylic acid Pending CN116514864A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN202310473843.2A CN116514864A (en) 2023-04-28 2023-04-28 Preparation method of (2S, 4R) -1- (tert-butyloxycarbonyl) -4- (tert-butyldimethylsilyloxy) -2-methylpyrrolidine-2-carboxylic acid

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN202310473843.2A CN116514864A (en) 2023-04-28 2023-04-28 Preparation method of (2S, 4R) -1- (tert-butyloxycarbonyl) -4- (tert-butyldimethylsilyloxy) -2-methylpyrrolidine-2-carboxylic acid

Publications (1)

Publication Number Publication Date
CN116514864A true CN116514864A (en) 2023-08-01

Family

ID=87405970

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202310473843.2A Pending CN116514864A (en) 2023-04-28 2023-04-28 Preparation method of (2S, 4R) -1- (tert-butyloxycarbonyl) -4- (tert-butyldimethylsilyloxy) -2-methylpyrrolidine-2-carboxylic acid

Country Status (1)

Country Link
CN (1) CN116514864A (en)

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101372472A (en) * 2007-08-24 2009-02-25 扬子江药业集团上海海尼药业有限公司 Method for synthesizing Zofenopril
CN105517574A (en) * 2013-07-09 2016-04-20 百时美施贵宝公司 Combinations of hepatitis c virus inhibitors
CN112898177A (en) * 2021-03-03 2021-06-04 浙江司太立制药股份有限公司 Preparation method of iomeprol impurity
WO2023041756A1 (en) * 2021-09-20 2023-03-23 F. Hoffmann-La Roche Ag New compounds and their use in the treatment of bacterial infection

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101372472A (en) * 2007-08-24 2009-02-25 扬子江药业集团上海海尼药业有限公司 Method for synthesizing Zofenopril
CN105517574A (en) * 2013-07-09 2016-04-20 百时美施贵宝公司 Combinations of hepatitis c virus inhibitors
CN112898177A (en) * 2021-03-03 2021-06-04 浙江司太立制药股份有限公司 Preparation method of iomeprol impurity
WO2023041756A1 (en) * 2021-09-20 2023-03-23 F. Hoffmann-La Roche Ag New compounds and their use in the treatment of bacterial infection

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
JOHN WATTS等: "Structure-Reactivity Studies of Simple 4-Hydroxyprolinamide Organocatalysts in the Asymmetric Michael Addition Reaction of Aldehydes to Nitroolefins", ADVANCED SYNTHESIS & CATALYSIS, vol. 354, no. 6, 12 April 2012 (2012-04-12), pages 1035 - 1042 *
VINCENT FEREY等: "Asymmetric Synthesis of α-Alkylproline Derivatives from a Chiral Borane−Amine Adduct: Inversion of Enantioselectivity in the Presence of a Crown Ether", THE JOURNAL OF ORGANIC CHEMISTRY, vol. 61, no. 21, 18 October 1996 (1996-10-18), pages 7244 - 7245 *

Similar Documents

Publication Publication Date Title
CN109096122B (en) Process for preparing spermidine
CN104250232A (en) Preparation method of parecoxib sodium
CN110590635A (en) Preparation method of levetiracetam and intermediate thereof
CN108440553A (en) A kind of method of the glabridin of the asymmetric syntheses optical purity of ruthenium complex catalysts
CN114213327A (en) Synthesis method of (-) -huperzine A
CN105524042B (en) A method of preparing bent Ge Lieting
WO2023000636A1 (en) Method for synthesis of (3-fluorooxetan-3-yl)methyl 4-methylbenzenesulfonate
CN116514864A (en) Preparation method of (2S, 4R) -1- (tert-butyloxycarbonyl) -4- (tert-butyldimethylsilyloxy) -2-methylpyrrolidine-2-carboxylic acid
CN103508999A (en) Maxacalcitol synthesizing intermediate and preparation method and application thereof
CN111116587A (en) Preparation method of avibactam intermediate compound
CN106366057A (en) Synthetic method of sofosbuvir intermediate
CN104974051A (en) Synthetic method for (1S,4R)-cis-4-amino-2-cyclopentene-1-methanol hydrochloride
CN109265385B (en) Synthesis process of chiral catalyst
CN116496314A (en) Preparation method of (2S, 4S) -1- (tert-butyloxycarbonyl) -4- (tert-butyldimethylsilyloxy) -2-methylpyrrolidine-2-carboxylic acid
CN116478076A (en) Preparation method of (2S, 4S) -1-tert-butoxycarbonyl-2- (difluoromethyl) -4-hydroxypyrrolidine
CN116396202A (en) Preparation method of (2S, 4S) -4-fluoropyrrolidine-2-carboxylic acid
CN107629039B (en) The preparation method and intermediate of deuterated acrylamide
CN116514665B (en) A preparation method of (R)-2,2,2-trifluoro-1-phenylethylamine hydrochloride
CN114195684B (en) Synthesis method of amino protecting group N-substituted chiral amino acid
CN113582920B (en) Synthetic method of 4- (4-pyridyl) morpholine
CN116768799A (en) Preparation method of 4-fluoroimidazole
CN118812418B (en) A kind of preparation method of high-purity arecoline hydrobromide
CN113443995B (en) Preparation method of key intermediate of Gerastib
CN114436851B (en) Preparation method of N, N-dimethylbenzylamine and derivatives thereof
CN110759922B (en) Preparation method of 6-benzyl-2, 6, 9-triazaspiro [4.5] decane-2-carboxylic acid tert-butyl ester

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination